These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8027685)

  • 1. [Are angiotensin-converting enzyme inhibitors the treatment of choice for arterial hypertension in patients with arteritis?].
    Priollet P; Lazareth I; Agnès E
    J Mal Vasc; 1994; 19(1):66-7. PubMed ID: 8027685
    [No Abstract]   [Full Text] [Related]  

  • 2. Three new ACE inhibitors for hypertension.
    Med Lett Drugs Ther; 1991 Sep; 33(852):83-4. PubMed ID: 1831531
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ambulatory multicenter study of Triatec (ramipril). Observations concerning the lessons of the trial for the realization of future trials and for the management of hypertensive patients].
    Battaglia C; Gallet M; Carré A
    Rev Prat; 1990 Jun; 40(18 Suppl):45-7. PubMed ID: 2143598
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of a new angiotensin-converting enzyme inhibitor, ramipril, vs. enalapril in essential hypertension: a multicenter trial.
    Mroczek WJ
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S147-9. PubMed ID: 1725028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ramipril: a review of the new ACE inhibitor.
    Mills TP
    J Ark Med Soc; 1992 Feb; 88(9):437-40. PubMed ID: 1532570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response relationship of ramipril in patients with mild-to-moderate hypertension.
    Schnaper HW
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S128-30. PubMed ID: 1725021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac and vascular effects of chronic angiotensin converting enzyme inhibition at subantihypertensive doses.
    Gohlke P; Stoll M; Lamberty V; Mattfeld T; Mall G; van Even P; Martorana P; Unger T
    J Hypertens Suppl; 1992 Aug; 10(6):S141-4. PubMed ID: 1432317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of converting enzyme inhibitors on hypertensive large arteries in humans.
    Safar ME; Laurent SL; Bouthier JD; London GM; Mimran AR
    J Hypertens Suppl; 1986 Dec; 4(5):S285-9. PubMed ID: 3033179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of Triatec in monotherapy and in combination with Lasilix in a French multicenter study].
    Guyot D; Lemarié JC
    Rev Prat; 1990 Jun; 40(18 Suppl):27-30, 35-8. PubMed ID: 2143596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ramipril on arterial hemodynamics.
    Benetos A; Vasmant D; Thiéry P; Safar M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S153-6. PubMed ID: 1725030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of ramipril on ambulatory blood pressure: a multicenter trial.
    Burris JF
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S131-3. PubMed ID: 1725022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of response rates to the angiotensin-converting enzyme inhibitor ramipril in mild-to-moderate hypertension in a double-blind, parallel-group study and an open single-blind study.
    Vasmant D; Lendresse P; Lemarie JC; Gallet M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S144-6. PubMed ID: 1725027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of ramipril against atenolol in controlling mild-to-moderate hypertension.
    Lenox-Smith AJ; Street RB; Kendall FD
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S150-2. PubMed ID: 1725029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The French ambulatory multicenter trial of Triatec: conclusions of the trial].
    Le Menn G
    Rev Prat; 1990 Jun; 40(18 Suppl):48-50. PubMed ID: 2143599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the new oral angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) in essential hypertension.
    Felder K; Witte PU
    Arzneimittelforschung; 1984; 34(10B):1452-4. PubMed ID: 6097273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The renin-angiotensin system and ramipril, a new converting enzyme inhibitor.
    Vasmant D; Bender N
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S46-52. PubMed ID: 2483429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the efficacy, tolerance, and safety of ramipril in diabetic patients with mild-to-moderate hypertension: a retrospective analysis.
    Erhard W; Lindner U; Krall H; Breitstadt A; Pfeiffer C
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S160-4. PubMed ID: 1725032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acronyms and myocardial infarction studies.
    Cheng TO
    Clin Cardiol; 1992 Apr; 15(4):A27. PubMed ID: 1532928
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo concentrations of kinins and angiotensins.
    Shimamoto K; Nakagawa M; Iimura O
    Horm Metab Res Suppl; 1990; 22():75-9. PubMed ID: 2143993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE inhibition - present and future. The role of ramipril. Proceedings of International Symposium. London, October 12-13, 1990.
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S1-183. PubMed ID: 1725014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.